Skip to main content
Home
User account menu
  • New account request
  • Log in

Baseline Monograph - White Men: Medications: Current Prescriptions

Back to Baseline Monograph


Age In Three Categories
65-6970-7980+
NUMBER OF MEDICATIONSNONE 211 32.5% 285 24.7% 80 22.9%
ONE 125 19.3% 231 20.1% 61 17.4%
TWO 124 19.1% 213 18.5% 68 19.4%
THREE 70 10.8% 164 14.2% 48 13.7%
FOUR 50 7.7% 105 9.1% 38 10.9%
FIVE 25 3.9% 56 4.9% 21 6.0%
SIX TO NINE 42 6.5% 90 7.8% 32 9.1%
TEN OR MORE 2 .3% 8 .7% 2 .6%
ANY CALCIUM CHANNEL BLOCKERNO 570 87.8% 998 86.6% 307 87.7%
YES 79 12.2% 154 13.4% 43 12.3%
DIGITALISNO 595 91.7% 1036 89.9% 299 85.4%
YES 54 8.3% 116 10.1% 51 14.6%
NITRATESNO 601 92.6% 1029 89.3% 293 83.7%
YES 48 7.4% 123 10.7% 57 16.3%
CLASS 1A ANTI-ARRHYTHMICSNO 636 98.0% 1114 96.7% 339 96.9%
YES 13 2.0% 38 3.3% 11 3.1%
ANY LIPID LOWERING MEDICATIONNO 619 95.4% 1096 95.1% 341 97.4%
YES 30 4.6% 56 4.9% 9 2.6%
ORAL HYPOGLYCEMICSNO 603 92.9% 1062 92.2% 331 94.6%
YES 46 7.1% 90 7.8% 19 5.4%
INSULINNO 635 97.8% 1124 97.6% 347 99.1%
YES 14 2.2% 28 2.4% 3 .9%
PHOSPHODIESTERASE INHIBITORSNO 630 97.1% 1102 95.7% 332 94.9%
YES 19 2.9% 50 4.3% 18 5.1%
SYMPATHOMIMETIC (ADRENERGIC) AGENTSNO 631 97.2% 1124 97.6% 343 98.0%
YES 18 2.8% 28 2.4% 7 2.0%
TRI- (& TETRA-) CYCLIC ANTI-DEPRESSANTSNO 636 98.0% 1135 98.5% 344 98.3%
YES 13 2.0% 17 1.5% 6 1.7%
NON-TRICYCLIC ANTIDEPRESSANTSNO 645 99.4% 1141 99.0% 348 99.4%
YES 4 .6% 11 1.0% 2 .6%
COMB. DRUGS--TRICYCLICS & ANTI-PSYCHOTICSNO 647 99.7% 1149 99.7% 350 100.0%
YES 2 .3% 3 .3%

ANTI-PSYCHOTICSNO 648 99.8% 1150 99.8% 350 100.0%
YES 1 .2% 2 .2%

ASPIRIN (ANTI-INFLAM AGENTS)NO 623 96.0% 1099 95.4% 337 96.3%
YES 26 4.0% 53 4.6% 13 3.7%
NON-STEROIDAL ANTI-INFLAM (NO ASPIRIN)NO 586 90.3% 1038 90.1% 310 88.6%
YES 63 9.7% 114 9.9% 40 11.4%
BENZODIAZEPINESNO 608 93.7% 1076 93.4% 318 90.9%
YES 41 6.3% 76 6.6% 32 9.1%
ANY ACE INHIBITORNO 605 93.2% 1060 92.0% 324 92.6%
YES 44 6.8% 92 8.0% 26 7.4%
ANY DIURETICNO 516 79.5% 888 77.1% 241 68.9%
YES 133 20.5% 264 22.9% 109 31.1%
ANY HYPERTENSION MEDNO 394 60.7% 627 54.4% 189 54.0%
YES 255 39.3% 525 45.6% 161 46.0%
ANY BETA BLOCKERNO 551 84.9% 975 84.6% 313 89.4%
YES 98 15.1% 177 15.4% 37 10.6%
ANY VASO DILATORNO 607 93.5% 1074 93.2% 331 94.6%
YES 42 6.5% 78 6.8% 19 5.4%

Main navigation

  • Home
  • About CHS
    • CHS Overview
    • Design, Rationale and Objectives
    • Principal Investigators and Study Sites
    • CHS Listing at NHLBI
  • Researchers
    • Welcome New Investigators
    • Working Groups
    • Data & Specimens
    • Data Documentation
    • Ancillary Studies
    • Publications Policy
    • Presentations Policy
    • Funding CHS
    • Forms & Agreements
  • Participants
    • Newsletters
    • CHS Healthy Life Calculator
  • Contact Us
  • FAQ
  • Log in

Search